Tivic Health reports advancements in vagus nerve stimulation

Tivic Health Systems, Inc. held its Q4 earnings call on March 21, 2025. The company discussed its financial results for the year and provided updates on its operations. During the call, CEO Jennifer Ernst highlighted significant developments from 2024. She noted that many of the company’s achievements have only come to fruition recently. Tivic has made progress in its vagus nerve stimulation program, which showed promising results early in 2025. Interim CFO Lisa Wolf also participated, but specific financial figures were not mentioned in the summary. The management encouraged investors to review their press release and other filings with the SEC for detailed financial information. The call included forward-looking statements, cautioning investors that actual results might differ from the company’s predictions. A replay of the call will be available on Tivic's website for three months.